Key Insights
The global nasal swab market, valued at $420 million in 2025, is projected to experience robust growth, driven by the increasing prevalence of respiratory infections and the rising demand for accurate and reliable diagnostic testing. The market's Compound Annual Growth Rate (CAGR) of 5.2% from 2025 to 2033 indicates a steady expansion, fueled by advancements in diagnostic technologies and the growing adoption of point-of-care testing. Key drivers include the increasing incidence of infectious diseases like influenza and COVID-19, necessitating widespread testing. Furthermore, the rising prevalence of chronic respiratory conditions, such as asthma and cystic fibrosis, contributes to the demand for nasal swabs for sample collection. Technological advancements, such as the development of more efficient and comfortable swab designs, also contribute to market growth. While regulatory hurdles and variations in healthcare infrastructure across different regions could pose challenges, the overall market outlook remains positive.

Nasal Swab Market Size (In Million)

The market is segmented based on swab type (e.g., flocked, rayon), application (e.g., diagnostics, research), and end-user (e.g., hospitals, clinics, research laboratories). Key players like BD, Copan Group, Puritan Medical Products, Thermo Fisher, Medical Wire (MWE), FL Medical, Deltalab, and Kangjian Medical are actively involved in research and development, focusing on innovation and expansion into new geographical markets. Competition is expected to intensify as companies strive to improve product quality, enhance efficiency, and offer cost-effective solutions to healthcare providers. The increasing integration of nasal swab technology into automated testing platforms further propels the market's growth. Despite potential economic fluctuations impacting healthcare spending, the crucial role of nasal swabs in disease diagnosis and management ensures sustained demand in the foreseeable future.

Nasal Swab Company Market Share

Nasal Swab Market Report: A Comprehensive Analysis of a Multi-Billion Dollar Industry (2019-2033)
This comprehensive report provides an in-depth analysis of the global nasal swab market, projecting a valuation exceeding $XX billion by 2033. It covers market dynamics, leading players, industry trends, and future opportunities, offering invaluable insights for stakeholders across the healthcare sector. The study period spans 2019-2033, with 2025 serving as the base and estimated year. The forecast period is 2025-2033, and the historical period is 2019-2024.
Nasal Swab Market Dynamics & Concentration
The global nasal swab market exhibits a moderately concentrated landscape, with key players like BD, Copan Group, Puritan Medical Products, Thermo Fisher Scientific, Medical Wire (MWE), FL Medical, Deltalab, and Kangjian Medical holding significant market shares. The market share distribution is dynamic, with ongoing mergers and acquisitions (M&A) impacting the competitive structure. Over the historical period (2019-2024), there were approximately xx M&A deals, primarily driven by strategies for market expansion and technological integration. Innovation is a crucial driver, with companies continually introducing improved swab materials, designs, and collection methods. Regulatory frameworks, particularly those related to infection control and quality standards, influence market growth. Product substitutes, while limited, include alternative sampling methods such as saliva collection, but nasal swabs maintain dominance due to their efficacy and established protocols. End-user trends, influenced by advancements in diagnostics and pandemic preparedness, are pushing demand for high-quality, reliable nasal swabs.
Nasal Swab Industry Trends & Analysis
The nasal swab market is experiencing robust growth, with a Compound Annual Growth Rate (CAGR) estimated at xx% during the forecast period (2025-2033). This growth is fueled by several factors. The rising prevalence of respiratory infections, increased demand for rapid diagnostic testing, and the expansion of point-of-care testing contribute significantly. Technological advancements, such as the development of swabs optimized for specific diagnostic techniques (e.g., PCR, antigen tests), are driving market penetration. Consumer preferences are shifting towards user-friendly, comfortable, and effective swabs, leading manufacturers to focus on ergonomic designs and material innovations. Competitive dynamics are characterized by intense innovation, strategic partnerships, and ongoing efforts to enhance product quality and cost-effectiveness. Market penetration is increasing significantly across various geographical regions, driven by improving healthcare infrastructure and rising awareness of respiratory illnesses.
Leading Markets & Segments in Nasal Swab
The North American market currently holds the leading position in the global nasal swab market, driven by factors such as high healthcare expenditure, robust diagnostic infrastructure, and stringent regulatory compliance. Key drivers in this region include:
- Advanced healthcare infrastructure: Extensive laboratory networks and well-established healthcare systems support the high demand for nasal swabs.
- High prevalence of respiratory illnesses: High rates of influenza, respiratory syncytial virus (RSV), and other respiratory infections fuel demand.
- Stringent regulatory frameworks: Strong regulatory bodies ensure high-quality products, driving market growth.
Other significant markets include Europe and Asia-Pacific, experiencing steady growth due to factors such as increased healthcare investments and rising awareness of infectious diseases. However, regional disparities persist, linked to variations in healthcare infrastructure and economic development levels. The market is segmented primarily by type (e.g., flocked swabs, rayon swabs), application (e.g., diagnostics, research), and end-user (e.g., hospitals, clinics). While each segment contributes to market growth, the diagnostic application sector dominates, reflecting the widespread use of nasal swabs in rapid testing.
Nasal Swab Product Developments
Recent innovations have focused on enhancing swab materials, improving collection efficiency, and integrating swabs with other diagnostic tools. For example, flocked swabs offer superior sample collection and release, while novel materials are being explored to minimize patient discomfort and improve sample integrity. These advancements are directly improving the accuracy and reliability of diagnostic tests, driving adoption and market expansion. The market is also seeing a surge in integrated systems that combine the swab with sample collection tubes and transport media.
Key Drivers of Nasal Swab Growth
Technological advancements in diagnostics, particularly rapid molecular testing and improved sensitivity of diagnostic assays, are primary drivers. The global increase in respiratory infections and pandemic preparedness initiatives significantly influence demand. Favorable regulatory environments that support innovation and expedite product approvals are also essential catalysts.
Challenges in the Nasal Swab Market
Supply chain disruptions and fluctuations in raw material costs pose significant challenges. Stringent regulatory requirements for medical devices can increase the time and cost of product development and market entry. Intense competition among manufacturers puts pressure on pricing and profit margins.
Emerging Opportunities in Nasal Swab
Technological breakthroughs in biosensors and microfluidics offer opportunities to integrate nasal swabs with miniaturized diagnostic devices, enabling rapid point-of-care testing. Strategic partnerships between swab manufacturers and diagnostic companies are driving the development of integrated systems. Market expansion into emerging economies with rising healthcare spending offers significant growth potential.
Leading Players in the Nasal Swab Sector
- BD
- Copan Group
- Puritan Medical Products
- Thermo Fisher Scientific
- Medical Wire (MWE)
- FL Medical
- Deltalab
- Kangjian Medical
Key Milestones in Nasal Swab Industry
- 2020: Increased demand for nasal swabs due to the COVID-19 pandemic.
- 2021: Several companies invested heavily in expanding manufacturing capacity to meet the surge in demand.
- 2022: Focus shifted towards innovative swab designs and materials to improve sample collection and testing efficiency.
- 2023: Increased collaborations between diagnostic companies and swab manufacturers.
Strategic Outlook for Nasal Swab Market
The nasal swab market is poised for continued growth, driven by technological innovation and increasing demand for rapid diagnostic testing. Strategic opportunities lie in developing integrated diagnostic platforms, expanding into new markets, and focusing on product differentiation through superior quality and innovative features. The market’s future hinges on adapting to evolving regulatory landscapes, responding to supply chain challenges, and anticipating future infectious disease outbreaks.
Nasal Swab Segmentation
-
1. Application
- 1.1. Hospital
- 1.2. Clinic
- 1.3. Other
-
2. Types
- 2.1. Foam Tipped Swabs
- 2.2. Non Woven
- 2.3. Other
Nasal Swab Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific

Nasal Swab Regional Market Share

Geographic Coverage of Nasal Swab
Nasal Swab REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 8.2% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Restrains
- 3.4. Market Trends
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Nasal Swab Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Application
- 5.1.1. Hospital
- 5.1.2. Clinic
- 5.1.3. Other
- 5.2. Market Analysis, Insights and Forecast - by Types
- 5.2.1. Foam Tipped Swabs
- 5.2.2. Non Woven
- 5.2.3. Other
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. South America
- 5.3.3. Europe
- 5.3.4. Middle East & Africa
- 5.3.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Application
- 6. North America Nasal Swab Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Application
- 6.1.1. Hospital
- 6.1.2. Clinic
- 6.1.3. Other
- 6.2. Market Analysis, Insights and Forecast - by Types
- 6.2.1. Foam Tipped Swabs
- 6.2.2. Non Woven
- 6.2.3. Other
- 6.1. Market Analysis, Insights and Forecast - by Application
- 7. South America Nasal Swab Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Application
- 7.1.1. Hospital
- 7.1.2. Clinic
- 7.1.3. Other
- 7.2. Market Analysis, Insights and Forecast - by Types
- 7.2.1. Foam Tipped Swabs
- 7.2.2. Non Woven
- 7.2.3. Other
- 7.1. Market Analysis, Insights and Forecast - by Application
- 8. Europe Nasal Swab Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Application
- 8.1.1. Hospital
- 8.1.2. Clinic
- 8.1.3. Other
- 8.2. Market Analysis, Insights and Forecast - by Types
- 8.2.1. Foam Tipped Swabs
- 8.2.2. Non Woven
- 8.2.3. Other
- 8.1. Market Analysis, Insights and Forecast - by Application
- 9. Middle East & Africa Nasal Swab Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Application
- 9.1.1. Hospital
- 9.1.2. Clinic
- 9.1.3. Other
- 9.2. Market Analysis, Insights and Forecast - by Types
- 9.2.1. Foam Tipped Swabs
- 9.2.2. Non Woven
- 9.2.3. Other
- 9.1. Market Analysis, Insights and Forecast - by Application
- 10. Asia Pacific Nasal Swab Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Application
- 10.1.1. Hospital
- 10.1.2. Clinic
- 10.1.3. Other
- 10.2. Market Analysis, Insights and Forecast - by Types
- 10.2.1. Foam Tipped Swabs
- 10.2.2. Non Woven
- 10.2.3. Other
- 10.1. Market Analysis, Insights and Forecast - by Application
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 BD
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Copan Group
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Puritan Medical Products
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Thermo Fisher
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Medical Wire (MWE)
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 FL Medical
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Deltalab
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Kangjian Medical
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.1 BD
List of Figures
- Figure 1: Global Nasal Swab Revenue Breakdown (undefined, %) by Region 2025 & 2033
- Figure 2: North America Nasal Swab Revenue (undefined), by Application 2025 & 2033
- Figure 3: North America Nasal Swab Revenue Share (%), by Application 2025 & 2033
- Figure 4: North America Nasal Swab Revenue (undefined), by Types 2025 & 2033
- Figure 5: North America Nasal Swab Revenue Share (%), by Types 2025 & 2033
- Figure 6: North America Nasal Swab Revenue (undefined), by Country 2025 & 2033
- Figure 7: North America Nasal Swab Revenue Share (%), by Country 2025 & 2033
- Figure 8: South America Nasal Swab Revenue (undefined), by Application 2025 & 2033
- Figure 9: South America Nasal Swab Revenue Share (%), by Application 2025 & 2033
- Figure 10: South America Nasal Swab Revenue (undefined), by Types 2025 & 2033
- Figure 11: South America Nasal Swab Revenue Share (%), by Types 2025 & 2033
- Figure 12: South America Nasal Swab Revenue (undefined), by Country 2025 & 2033
- Figure 13: South America Nasal Swab Revenue Share (%), by Country 2025 & 2033
- Figure 14: Europe Nasal Swab Revenue (undefined), by Application 2025 & 2033
- Figure 15: Europe Nasal Swab Revenue Share (%), by Application 2025 & 2033
- Figure 16: Europe Nasal Swab Revenue (undefined), by Types 2025 & 2033
- Figure 17: Europe Nasal Swab Revenue Share (%), by Types 2025 & 2033
- Figure 18: Europe Nasal Swab Revenue (undefined), by Country 2025 & 2033
- Figure 19: Europe Nasal Swab Revenue Share (%), by Country 2025 & 2033
- Figure 20: Middle East & Africa Nasal Swab Revenue (undefined), by Application 2025 & 2033
- Figure 21: Middle East & Africa Nasal Swab Revenue Share (%), by Application 2025 & 2033
- Figure 22: Middle East & Africa Nasal Swab Revenue (undefined), by Types 2025 & 2033
- Figure 23: Middle East & Africa Nasal Swab Revenue Share (%), by Types 2025 & 2033
- Figure 24: Middle East & Africa Nasal Swab Revenue (undefined), by Country 2025 & 2033
- Figure 25: Middle East & Africa Nasal Swab Revenue Share (%), by Country 2025 & 2033
- Figure 26: Asia Pacific Nasal Swab Revenue (undefined), by Application 2025 & 2033
- Figure 27: Asia Pacific Nasal Swab Revenue Share (%), by Application 2025 & 2033
- Figure 28: Asia Pacific Nasal Swab Revenue (undefined), by Types 2025 & 2033
- Figure 29: Asia Pacific Nasal Swab Revenue Share (%), by Types 2025 & 2033
- Figure 30: Asia Pacific Nasal Swab Revenue (undefined), by Country 2025 & 2033
- Figure 31: Asia Pacific Nasal Swab Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Nasal Swab Revenue undefined Forecast, by Application 2020 & 2033
- Table 2: Global Nasal Swab Revenue undefined Forecast, by Types 2020 & 2033
- Table 3: Global Nasal Swab Revenue undefined Forecast, by Region 2020 & 2033
- Table 4: Global Nasal Swab Revenue undefined Forecast, by Application 2020 & 2033
- Table 5: Global Nasal Swab Revenue undefined Forecast, by Types 2020 & 2033
- Table 6: Global Nasal Swab Revenue undefined Forecast, by Country 2020 & 2033
- Table 7: United States Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 8: Canada Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 9: Mexico Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 10: Global Nasal Swab Revenue undefined Forecast, by Application 2020 & 2033
- Table 11: Global Nasal Swab Revenue undefined Forecast, by Types 2020 & 2033
- Table 12: Global Nasal Swab Revenue undefined Forecast, by Country 2020 & 2033
- Table 13: Brazil Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 14: Argentina Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 15: Rest of South America Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 16: Global Nasal Swab Revenue undefined Forecast, by Application 2020 & 2033
- Table 17: Global Nasal Swab Revenue undefined Forecast, by Types 2020 & 2033
- Table 18: Global Nasal Swab Revenue undefined Forecast, by Country 2020 & 2033
- Table 19: United Kingdom Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 20: Germany Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 21: France Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 22: Italy Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 23: Spain Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 24: Russia Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 25: Benelux Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 26: Nordics Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 27: Rest of Europe Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 28: Global Nasal Swab Revenue undefined Forecast, by Application 2020 & 2033
- Table 29: Global Nasal Swab Revenue undefined Forecast, by Types 2020 & 2033
- Table 30: Global Nasal Swab Revenue undefined Forecast, by Country 2020 & 2033
- Table 31: Turkey Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 32: Israel Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 33: GCC Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 34: North Africa Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 35: South Africa Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 36: Rest of Middle East & Africa Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 37: Global Nasal Swab Revenue undefined Forecast, by Application 2020 & 2033
- Table 38: Global Nasal Swab Revenue undefined Forecast, by Types 2020 & 2033
- Table 39: Global Nasal Swab Revenue undefined Forecast, by Country 2020 & 2033
- Table 40: China Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 41: India Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 42: Japan Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 43: South Korea Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 44: ASEAN Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 45: Oceania Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 46: Rest of Asia Pacific Nasal Swab Revenue (undefined) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Nasal Swab?
The projected CAGR is approximately 8.2%.
2. Which companies are prominent players in the Nasal Swab?
Key companies in the market include BD, Copan Group, Puritan Medical Products, Thermo Fisher, Medical Wire (MWE), FL Medical, Deltalab, Kangjian Medical.
3. What are the main segments of the Nasal Swab?
The market segments include Application, Types.
4. Can you provide details about the market size?
The market size is estimated to be USD XXX N/A as of 2022.
5. What are some drivers contributing to market growth?
N/A
6. What are the notable trends driving market growth?
N/A
7. Are there any restraints impacting market growth?
N/A
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2900.00, USD 4350.00, and USD 5800.00 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in N/A.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Nasal Swab," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Nasal Swab report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Nasal Swab?
To stay informed about further developments, trends, and reports in the Nasal Swab, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

